Skip to main content
HUMANA INC logo

HUMANA INC — Investor Relations & Filings

Ticker · HUM ISIN · US4448591028 LEI · 529900YLDW34GJAO4J06 US Financial and insurance activities
Open in API
Filings indexed 3,056 across all filing types
Latest filing 2015-10-13 Merger & Acquisition
Country US United States of America
Listing US HUM

About HUMANA INC

https://www.humana.com/

Humana Inc. is a health and well-being company offering a broad range of health insurance products and healthcare services. The company primarily focuses on providing Medicare plans, including Medicare Advantage and Prescription Drug Plans (Part D), to eligible individuals. Beyond its Medicare offerings, Humana provides other medical and specialty insurance products. The company operates through two main segments: Insurance, which encompasses its health plans, and CenterWell, which delivers healthcare services such as primary care, pharmacy operations, and in-home care. Humana is committed to a personalized and simplified whole-person healthcare approach, aiming to help its members achieve better health outcomes through integrated care and wellness solutions.

Recent filings

Filing Released Lang Actions
425 Filing
Merger & Acquisition Classification · 95% confidence The document is filed by Aetna Inc. pursuant to Rule 425 of the Securities Act of 1933 and Rule 14a-6(b) of the Securities Exchange Act of 1934. It contains excerpts from a CNBC interview discussing the proposed transaction between Aetna and Humana. The text references a registration statement on Form S-4, a joint proxy statement/prospectus, and urges investors to read these documents carefully. The content focuses on the solicitation of proxies related to the merger transaction and includes cautionary forward-looking statements. There is no detailed financial data or comprehensive financial report included; rather, it is a communication related to the merger and proxy solicitation. Rule 425 filings are typically merger communications and fall under merger-related filings. Therefore, the document is best classified as a Merger & Acquisition (MA) filing.
2015-10-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the settlement of litigation related to mergers, supplemental disclosures to a previously filed definitive proxy statement, and detailed financial projections related to the merger. It references the Proxy Statement and provides additional disclosures and updates to it. The document is not a full annual or quarterly report, nor is it a transcript, audit report, or earnings release. It is not a proxy solicitation itself but supplements a proxy statement. The document is a regulatory filing that provides material event updates and supplemental information related to merger litigation and disclosures. Given the nature of the Form 8-K and the detailed supplemental disclosures, this filing best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not neatly fit into other categories but are official SEC filings providing important updates.
2015-10-09 English
425 Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the settlement of litigation related to mergers, supplemental disclosures to a previously filed definitive proxy statement, and detailed financial projections related to the merger. It references the proxy statement multiple times and provides additional disclosures and financial data supplementing that proxy statement. The document is not a full annual or quarterly report, nor is it a transcript, audit report, or earnings release. It is not a proxy solicitation itself but supplements a proxy statement. The document is lengthy (15,000 characters) and contains substantive information about the merger litigation settlement and financial projections, which are material events. Given the nature of the content—settlement of litigation related to mergers and supplemental disclosures to a proxy statement—the best classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit neatly into other categories like M&A filings or proxy solicitation. It is not a merger filing (MA) because it is not the merger communication or proxy statement itself but a current report supplementing it. Therefore, the classification is RNS with high confidence.
2015-10-09 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document is a communication filed by Aetna Inc. pursuant to Rule 425 of the Securities Act of 1933 and Rule 14a-6(b) of the Securities Exchange Act of 1934. It discusses the proposed merger between Aetna and Humana, including an op-ed about health insurance mergers and competition, and provides detailed information about the proxy solicitation process, regulatory filings, and forward-looking statements related to the merger. The document references the Form S-4 registration statement and the joint proxy statement/prospectus filed with the SEC. It is not a full merger proxy statement itself but rather a communication related to the merger process and proxy solicitation. Given the detailed discussion of the merger and proxy solicitation, and the fact that it is filed under Rule 425 (which is used for communications related to mergers and acquisitions), the document fits best into the category of Merger & Acquisition (MA). The length and content indicate it is not a brief announcement or a simple regulatory filing but a substantive communication related to the merger transaction.
2015-10-07 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document is filed pursuant to Rule 425 under the Securities Act of 1933 and Rule 14a-12 under the Securities Exchange Act of 1934, which are commonly used for merger communications. It discusses the proposed merger between Humana Inc. and Aetna, including FAQs about the merger, definitions of merger-related terms, and references to the joint proxy statement/prospectus filed with the SEC. The document also mentions the solicitation of proxies and provides detailed information about the merger process, integration plans, and shareholder meetings. The presence of detailed merger-related information and the reference to Rule 425 filings indicate this is a merger communication document. According to the filing definitions, merger communications such as those filed under Rule 425 are classified under Merger & Acquisition (Code: MA). The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or a brief summary, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the correct classification is Merger & Acquisition (MA).
2015-10-06 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document is filed by Aetna Inc. pursuant to Rule 425 of the Securities Act of 1933 and Rule 14a-6(b) of the Securities Exchange Act of 1934, which are rules related to merger communications and proxy solicitations. It references a Form S-4 registration statement and a joint proxy statement/prospectus related to the proposed acquisition of Humana Inc. by Aetna. The text includes excerpts from an all-employee meeting discussing the acquisition, strategic implications, and forward-looking statements about the transaction. There is no presentation of financial statements or detailed financial results, but rather a communication related to the merger process and solicitation of proxies. The presence of Rule 425 filing and discussion of proxy materials indicates this is a merger-related communication. Therefore, the document fits best under the category of Merger & Acquisition (MA), which includes merger communications such as Form 425 filings.
2015-10-05 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.